AMETEK, Inc. AME has reported first-quarter 2024 adjusted earnings of $1.64 per share, beating the Zacks Consensus Estimate by 3.1%. The bottom line rose 10% on a year-over-year basis. Net sales of $1.74 billion increased 9% from the year-ago quarter. However, the figure missed the Zacks Consensus Estimate of $1.78 billion. Top-line growth was primarily driven by the solid performance of the Electromechanical Group (EMG) segment. Also, strength in the Electronic Instruments Group (EIG) segment contributed well. AMETEK’s proper execution of the four core growth strategies — operational excellence, global market expansion, investments in product development and acquisitions — is expected to continue aiding financial growth in the near and long term. The AMETEK Growth Model is likely to continue driving its business performance. AMETEK, Inc. Price, Consensus and EPS Surprise AMETEK, Inc. Price, Consensus and EPS Surprise AMETEK, Inc. price-consensus-eps-surprise-chart | AMETEK, Inc. Quote Segments in Detail EIG (66.6% of total sales): AMETEK generated sales of $1.16 billion from the segment, reflecting year-over-year growth of 4%. The figure missed the consensus mark of $1.19 billion. EMG (33.4%): The segment generated $579.4 million in sales in the first quarter, which improved 21% on a year-over-year basis. The figure lagged the Zacks Consensus Estimate of $590 million. Operating Details For the first quarter, operating expenses were $1.32 billion, up 10.7% year over year. The figure expanded 140 basis points (bps) from the year-ago quarter as a percentage of net sales to 76%. The operating margin was 24%, which contracted 140 bps from the year-ago quarter. The operating margin for EIG expanded 280 bps year over year to 30.5%. The same for EMG contracted 940 bps from the year-ago quarter to 15.7% due to Paragon integration costs. Balance Sheet As of Mar 31, 2024, cash and cash equivalents were $373.8 million, down from $409.8 million as of Dec 31, 2023. The long-term debt was $1.877 billion as of Mar 31, 2024, up from $1.895 billion as of Dec 31, 2023. Guidance For second-quarter 2024, management expects sales growth in the mid to high-single digits from the year-ago quarter’s reported figure. The Zacks Consensus Estimate is pegged at $1.84 billion. AMETEK expects adjusted earnings of $1.63-$1.65 per share, suggesting growth of 4-5% from the year-ago quarter’s reported number. The consensus mark is pinned at $1.66 per share. For 2024, AME expects sales growth in the low-double digits from the 2023 reported level. The Zacks Consensus Estimate is pegged at $7.37 billion. The company raised its guidance for adjusted earnings from $6.70-$6.85 per share to $6.74-$6.86, which suggests growth of 6-8% from the 2023 reported level. The Zacks Consensus Estimate for earnings is pegged at $6.82. Zacks Rank & Other Stocks to Consider AMETEK currently carries a Zacks Rank #2 (Buy). Some other top-ranked stocks in the broader technology sector are Arista Networks ANET, Alphabet GOOGL and Badger Meter BMI, each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here. Shares of Arista Networks have gained 8.9% in the year-to-date period. The long-term earnings growth rate for ANET is anticipated to be 17.48%. Shares of Alphabet have gained 16.5% in the year-to-date period. The long-term earnings growth rate for GOOGL is projected at 17.21%. Shares of Badger Meter have gained 18.7% in the year-to-date period. The long-term earnings growth rate for BMI is likely to be 15.57%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Badger Meter, Inc. (BMI):Free Stock Analysis Report AMETEK, Inc. (AME):Free Stock Analysis Report Alphabet Inc. (GOOGL):Free Stock Analysis Report Arista Networks, Inc. (ANET):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
AMETEK (AME) Q1 Earnings Surpass Estimates, Sales Rise Y/Y
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...